Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Market capitalisation, EUR | 49,194 m |
| EPS, EUR | - |
| P/B ratio | 9.2 |
| P/E ratio | 43.3 |
| Dividend yield | 0.00% |
| Revenue, EUR | 2,021 m |
| Net income, EUR | 769 m |
| Profit margin | 38.03% |
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| L&G Gerd Kommer Multifactor Equity UCITS ETF USD Distributing | 0.01% | Equity World Multi-Factor Strategy | 139 |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 2.16% | Equity United States Health Care Biotech | 44 |
| L&G Gerd Kommer Multifactor Equity UCITS ETF USD Accumulating | 0.01% | Equity World Multi-Factor Strategy | 755 |
| L&G Global Equity UCITS ETF | 0.07% | Equity World Social/Environmental | 941 |
| L&G Europe ex UK Equity UCITS ETF | 0.50% | Equity Europe Social/Environmental | 880 |
| Amundi Prime Eurozone UCITS ETF DR (D) | 0.74% | Equity Europe | 56 |
| L&G Pharma Breakthrough UCITS ETF | 2.81% | Equity World Health Care Innovation | 16 |
| Amundi Prime Europe UCITS ETF DR (D) | 0.40% | Equity Europe | 147 |